AKOYA_logo_white_smallAKOYA_logo_white_smallAKOYA_logo_white_smallAKOYA_logo_white_small
  • Our Statement on COVID-19
  • Search
  • Login
  • Contact Us
  • Products
    • Solutions
      • Why Multiplex Imaging
      • Discovery to Translation
      • Biopharma Services
    • Products
      • CODEX® – Ultrahigh Multiplexed Imaging
      • PhenopticsTM – High-throughput Multiplexed Imaging
      • ProximaTM – Cloud Storage & Collaboration
  • Technology
    • Intro to CODEX
    • Intro to Phenoptics
  • Support
    • Hardware
    • Software
    • Reagents
    • FAQs
  • Resources
    • Akoya Academy
    • Literature
    • Videos
    • Webinars
    • Publications
    • Blog
  • Company
    • About Us
    • Leadership
    • Partners
    • Careers
    • News
    • Media Kit
    • Upcoming Events
  • Products
    • Codex
    • Phenoptics
    • Proxima
  • Solutions
    • Why Multiplex Imaging?
    • Discovery to Translation
    • Biopharma Services
  • Technology
    • Intro to CODEX
    • Intro to Phenoptics
  • Support
    • Hardware
    • Software
    • Reagents
    • FAQs
  • Resources
    • Akoya Academy
    • Literature
    • Videos
    • Webinars
    • Publications
    • Blog
  • Company
    • About Us
    • Leadership
    • Partners
    • Careers
    • News
    • Media Kit
    • Upcoming Events
  • Home
  • From Research to Translational Medicine: Changing the Language of High Parameter Quantitative Tissue Analysis

From Research to Translational Medicine: Changing the Language of High Parameter Quantitative Tissue Analysis

Tuesday, May 21, 2019, 12:00 – 1:00PM Eastern (9:00 – 10:00AM Pacific)

Life science enterprises, including CROs, pharmaceutical companies and large academic medical centers are implementing large-scale, advanced quantitative multispectral image analysis. These applications have opened new avenues for cutting-edge research and discovery. As this trend continues to grow in both its scope and impact, the demand on core software functionality to facilitate management, collaboration, and broader translation of multispectral analysis has become an increasingly significant hurdle.

Join Proscia and Akoya Biosciences, two industry-leading multispectral analysis companies, as they share the exciting new ways their platforms address these hurdles and how they impact your high-throughput analysis workflows.

You Will Learn

  • How high-throughput tissue analysis workflows can drive your research
  • How Proscia simplifies and speeds up your digital pathology workflow
  • How Phenoptics enables better spatial biomarker discovery
Watch Webinar

Nathan Buchbinder
Chief Product Officer
Proscia, Inc.

Daniel Eversole, PhD
Product Manager
Akoya Biosciences, Inc.

Products

  • CODEX
  • Phenoptics
  • Proxima

Solutions

  • Why Multiplex Imaging
  • Discovery to Translation
  • Biopharma Services

Support

  • Hardware
  • Software
  • Reagents
  • FAQs

Technology

  • Intro to CODEX
  • Intro to Phenoptics

Resources

  • Akoya Academy
  • Literature
  • Videos
  • Webinars
  • Publications
  • Blog

Company

  • About Us
  • Leadership
  • Partners
  • Careers
  • News
  • Media Kit
  • Upcoming Events



Akoya Biosciences is a registered trademark and The Spatial Biology Company is a trademark of Akoya Biosciences, Inc. A Delaware corporation.
Copyright © 2019 All Rights Reserved | Terms and Conditions | Privacy Policy
    • Our Statement on COVID-19
    • Search
    • Login
    • Contact Us